Navigation Links
Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
Date:5/8/2012

ber of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.


'/>"/>
SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344
2. Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference
3. Marshall Edwards Announces Rights Offering to Stockholders
4. Marshall Edwards Adds $2 Million in Private Placement
5. Marshall Edwards Announces $2 Million Private Placement
6. Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
7. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
8. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
9. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
10. Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
11. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015  CipherHealth, a leading provider of innovations and ... sent representatives to the Nepalese American Nursing Association to ... nurses to Nepal to aid ... month. In addition to helping fund the travel costs ... for much-needed medical supplies for the mission.  ...
(Date:5/5/2015)... , May 5, 2015   InspireMD, Inc. ... embolic protection systems, announced today that it will release its ... 2015 on Monday, May 11 th before the open, ... review its financial results and business outlook. Participants ... or (412) 542-4135 (International) and request the InspireMD call. A ...
(Date:5/5/2015)...  Trovagene, Inc. (NASDAQ:  TROV), a developer of ... for the three months ended March 31, 2015. ... presented favorable clinical results at ASCO GI, AACR, ... Precision Cancer Monitoring platform,s ability to detect and ... cancers," said Antonius Schuh, Ph.D., chief executive officer ...
Breaking Medicine Technology:Five Nurses and Medical Supplies En Route to Nepal With Donation Assistance from CipherHealth 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6
... , , WASHINGTON, Dec. 8 A ... wise choice in today,s economy. The Bureau of Labor Statistics, ... faster than for the average occupation--up to a 32 percent ... part of the pharmacy team and are relied upon to ...
... Dec. 8 Micromet, Inc. (Nasdaq: MITI ), ... treatment of cancer, inflammation and autoimmune diseases, today announced ... blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL). ... the 51st Annual Meeting of the American Society of ...
Cached Medicine Technology:Pharmacy Technician Employment Increasing Up to 32% By 2016 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4
(Date:5/6/2015)... May 06, 2015 The beverage industry ... drinks. Little Miracles organic tea and superfruit fusions stands ... ginseng and sweetened with agave, these delicious juice blends ... that seeks healthier ways to hydrate. , In collaboration ... invites people to raise a bottle of Lemongrass Tea ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 The ... Florida Hospital Tampa has been recognized by the ... Level 4 Epilepsy Center. The role of a ... diagnosis of a patient’s seizure type and seizure ... caregivers, appropriate treatment specific to a patient’s diagnosis ...
(Date:5/5/2015)... Scottsdale, AZ (PRWEB) May 05, 2015 ... NCPDP’s Elite Partner Program. The program establishes a three-year ... to a maximum of 10 Elite Partners. “AmerisourceBergen has ... Ann Stember, President of NCPDP, “and this is a ... work. , We can trace AmerisourceBergen back to ...
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... ( Optimity) will present at the ... 20 at 1:15 p.m. MT in Scottsdale, AZ. ... the nation’s leading nonprofit authority on the use ... information exchange. Donald Graf, National Director of Telemedicine ...
(Date:5/5/2015)... Dallas, TX (PRWEB) May 05, 2015 ... has selected C.R. Bard Inc., a leading multinational ... technologies in the fields of vascular, urology, oncology ... its 2015 Vanguard Award. The Vanguard Award ... of employee wellness programs among Viverae’s significant client ...
Breaking Medicine News(10 mins):Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:Florida Hospital Tampa Epilepsy Program Earns Designation as a Level 4 Epilepsy Center by the National Association of Epilepsy Centers (NAEC) 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2
... in serious trouble after an eye infection was detected in ... products.// There are complaints arising from Asia, US and Europe ... might be linked to a spate of serious eye infections ... cases of the infection had also been confirmed in Europe. ...
... Dominique Samuels, whose burned body was found on Sunday, has ... nearby gas stations. //Police hope to find if anyone filled ... scouring gas stations near Franklin Park where the body was ... killed somewhere else before her body was moved to a ...
... poor quality of drinking water for the cholera cases that ... cases have been reported.// ,"The capital has reported 222 ... year. But we are not triggering the warning bell as ... municipal health officer of Delhi. ,"Waterborne diseases may ...
... which may be helpful in reducing the risk of ... more research is needed before it is implemented.// ... breast cancer through research and education in UK revealed ... 16 years, reported the online edition of Daily Mail. ...
... Doctors belonging to a hospital in Delhi is said to ... on Thursday. //They further claimed that the patient is the ... Sir Ganga Ram Hospital said that the girl from Gurgaon ... north India so far. ,"The child was suffering ...
... an explanation from the medical superintendent (MS) of the AIIMS ... inflicted with AIDS after undergoing blood transfusion in 2001. //The ... relevant documents were not being made available despite repeated requests. ... transfusion was the business of the public at large and ...
Cached Medicine News:
...
...
... Retriever is for arthroscopic and open soft tissue ... complicated procedural steps. It may be used ... and in conjunction with,anchors or screws (including suture ... needle tip permits the placement of a variety ...
Single step suture passage is made simple with Arthro-Pierce instruments. The low profile, highly sharpened tip allows easy passage through tissue in order to retrieve or apply suture....
Medicine Products: